Atezolizumab: Solution concentrate for I.V. infusion 840 mg in 14 mL; Tecentriq® Page last updated: 6 March 2020 Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB) Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)